IRIX (iridex.com) Short-Term Debt to Capital

IRIDEX Corp - graphic logo of issuer IRIX

The market valuation dynamics for IRIDEX Corporation (IRIX), which specializes in the development of ophthalmological lasers, stand at 0.05. Sales depend on insurance payouts, the availability of funds within clinics, and competition from new vision correction methods. Margins remain under pressure due to supply chain disruptions and potential lawsuits; however, the company maintains a strong R&D team and continues to attract experts in physician training.

Ratio of Short-Term Indebtedness to Capital: IRIDEX Corporation (IRIX) for 07/04/2022 - 10/30/2026
Signature product of IRIDEX Corp.

This indicator measures the share of short-term liabilities within the equity structure, allowing for an assessment of liquidity dependence on the cost of borrowed funds. By analyzing the ratio of short-term debt to equity, an investor can gauge the sensitivity of IRIDEX Corporation (IRIX) to regulatory rates, which, coupled with a stable revenue stream from laser system services, minimizes refinancing risks through a resilient installed equipment base.

Analysis of competing companies

Short-Term Debt to Capital DXCM|PEN (Penumbra Medical) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital NOVT (Novanta Inc.)|haemonetics.com (HAE) - Current Liabilities to Capital|INSP - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital PRCT (PROCEPT BioRobotics Corp)|CNMD: Short-Term Debt to Capital|Pulse Medical (PLSE) - Short-Term Debt to Capital|Short-Term Debt to Equity InMode Ltd.|picardmedical.com - Current Liabilities to Equity|Short-Term Debt to Capital SRDX|SENS - Current Liabilities to Capital|NeuroPace Corp - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tactile Systems Technology, Inc. TCMD|SNWV: Short-Term Debt to Equity Ratio|outsetmedical.com - Short-Term Loans to Capital Ratio|ELMD: Short-Term Debt to Capital|LNSR - Short-Term Debt to Capital Coefficient|RCEL (AVITA Medical, Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Profound Medical Corporation (PROF)|Short-Term Debt to Equity Ratio BDMD (Baird Medical Investment)|EDAP (edap-tms.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Apyx Medical Corporation APYX|ICCM - Short-Term Debt to Equity Ratio|Pulmonx Corp. - Short-Term Debt to Capital|Current Liabilities to Capital TELA Bio, Inc.|CTSO: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio SRTS|ZYXI (Zynex) - Short-Term Debt to Capital|electroCore Medical (ECOR) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital RBOT|Short-Term Debt to Equity Ratio inspira-technologies.com IINN|Short-Term Debt to Capital ICU (SeaStar Medical Holding)|Short-Term Debt to Capital Intelligent Bio Solutions Inc INBS|XAIR - Short-Term Debt to Equity|PFSA: Short-Term Debt to Equity|SSKN (strataskinsciences.com) - Short-Term Debt to Equity Ratio|GlucoTrack Inc. - Ratio of Short-Term Indebtedness to Capital|NAOV (NanoVibronix, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital venusconcept.com VERO|Short-Term Debt to Equity Nuwellis (NUWE)|Aethlon Medical Inc (AEMD) - Short-Term Indebtedness to Equity|Asensus Surgical - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Avinger Inc AVGR|BioSig - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient cutera.com CUTR|Know Labs (KNW) - Short-Term Debt to Equity|Current Liabilities to Equity NARI (Inari Medical Inc)|Short-Term Debt to Equity Nevro Corporation|Short-Term Debt to Equity Ratio ReShape Lifesciences Inc (RSLS)|Short-Term Debt to Capital SILK